SJSikirullai O. Jeje

Sikirullai O. Jeje

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sikirullai O. Jeje has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Y. Raji

    Laboratory for Reproductive Physiology and Developmental Programming, Department of Physiology, University of Ibadan, Ibadan, Nigeria

    3 shared publications
  • A. A. Fasanmade

    1 shared publication
  • Akinjide Moses Akinnuga

    School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa

    1 shared publication
  • Ayotunde S. Adeagbo

    Department of Physiology, School of Health and Health Technology, Federal University of Technology, Akure,Nigeria

    1 shared publication
  • E. E. Amaku

    Department of Human Physiology, Cross River University of Technology, Okuku Campus, Ogoja, Cross River State, Nigeria

    1 shared publication
  • F. O. Otogo

    Department of Human Physiology, Cross River University of Technology, Okuku Campus, Ogoja, Cross River State, Nigeria

    1 shared publication

Latest Publications

  • Vascular Dysfunction in the Brain; Implications for Heavy Metal Exposures

    by Nzube F. Olung, Oritoke M. Aluko, Sikirullai O. Jeje, Ayotunde S. Adeagbo, Omamuyovwi M. Ijomone

    : Normal or diseased conditions that alter the brain’s requirement for oxygen and nutrients via alterations to neurovascular coupling have an impact on the level of the neurovascular unit; comprising neuronal, glial and vascular components. The communications between the components of the neurovascular unit are precise and accurate for its functions; hence a minute disturbance can result in neurovascular dysfunction. Heavy metals such as cadmium, mercury, and lead have been identified to increase the vulnerability of the neurovascular unit to damage. This review examines the role of heavy metals in neurovascular dysfunctions and the possible mechanisms by which these metals act. Risk factors ranging from lifestyle, environment, genetics, infections, and physiologic ageing involved in neurological dysfunctions were highlighted, while stroke was discussed as the prevalent consequence of neurovascular dysfunctions. Furthermore, the role of these heavy metals in the pathogenesis of stroke consequently pinpoints the importance of understanding the mechanisms of neurovascular damage in a bid to curb the occurrence of neurovascular dysfunctions.


  • Maternal treatment with dexamethasone during gestation alters sexual development markers in the F1 and F2 male offspring of Wistar rats

    by S. O. Jeje, Y. Raji

    Maternal treatment with dexamethasone (Dex) in threatening preterm delivery alters activities at the hypothalamic–pituitary–adrenal axis in the offspring. This alteration may interfere with reproductive function. The impact of gestational Dex exposure on male reproductive function of the offspring was investigated. A total of 25 pregnant rats randomly assigned to five groups (n=5) were treated with normal saline (control), Dex (100 μg/kg/day sc) during gestation days (GD) 1–7, 8–14, 15–21 and 1–21, respectively. Birth weight, anogenital distance (AGD), pubertal age, sperm parameters, hormonal profile and histopathology of testis and epididymis were determined in the F1 and F2 offspring. Results showed a significant increase (PP1 offspring. In the F2 offspring, there was a significant reduction (PP1 and F2 offspring. Maternal Dex treatment in rats during late gestation may disrupt sexual development markers in the F1 and F2 male offspring.


    • 20 December 2015
      • Vol. 30, 131-7

    Effects of Maternal Dexamethasone Exposure During Lactation on Metabolic Imbalance and Oxidative Stress in the Liver of Male Offsprings of Wistar Rats.

    by S O Jeje, Yinusa Raji

    It has been reported in human and animal studies that early exposure to glucocorticoids could retard growth and subsequent development of cardio metabolic diseases. Chronic exposure to glucocorticoids induced oxidative stress. Therefore, the role of oxidative stress in some of the observed metabolic imbalance needs to be elucidated. This study examined the effects of lactational dexamethasone exposure on metabolic imbalance and oxidative stress marker in the liver of male offspring of exposed mother. Twenty lactating dams were divided into 4 groups of 5 animals each. Group 1 was administered 0.02 ml/100gbwt/day normal saline through lactation days 1-21. Group 2, 3, and 4 were administered 100 µg/kgbwt/day dexamethasone for lactation days 1-7, 1-14, and 1-21 respectively. The male offspring were thereafter separated and sacrificed at 12weeks of age for evaluation of lipid profile and oxidative stress marker in the liver. Results from this study indicate that Total Cholesterol (TC), Triglycerides (TAG) and LDL- cholesterol (LDL-C) were significantly higher in the Dex 1-7, Dex 1-14 and Dex 1-21 groups when compared with the control. HDL-Cholesterol (HDL-C) was significantly reduced in the Dex 1-7, Dex 1-14 and Dex 1-21 groups relative to the control. Basal Fasting Blood Sugar (FBS) was also significantly higher in the Dex 1-14 and Dex 1-21 groups when compared with the control. Liver malondialdehyde was significantly higher in the Dex1-14 and Dex1-21 group compared to the control. However, liver catalase and SOD activity were all significantly lower in Dex 1-7, Dex 1-14 and Dex 1-21 groups relative to control. Liver protein was significantly lower in the Dex1-14 and Dex1-21 treatment groups when compared with the control. Findings from this study suggest that there is possible increase in metabolic imbalance in the offspring of mother exposed to dexamethasone during lactation and these effects may be secondary to increase oxidative stress in the liver.


  • Open Access

    Effects of maternal dexamethasone exposure on hematological indices in the male offspring

    by So Jeje, Y Raji

    Maternal treatment with dexamethasone in threatening preterm delivery leads to high basal corticosterone level in the offspring. Excess glucocorticoids may inhibit the production of interleukin. This study examined the effects of prenatal and lactational dexamethasone exposure on hematological parameter in male offspring. The rats were divided into 9 groups. Group1 was administered 0.02 ml/100gbw/day normal saline throughout pregnancy. Group 2, 3, 4 and 5 were administered 100 ìg/kgbw/day dexamethasone through gestation day (GD) 1-7, 8-14, 15-21 and 1-21 respectively. Group 6 was administered 0.02 ml/100gbw/day normal saline at Lactational day (LD) 1-21. Group 7, 8 and 9 were administered 100 ìg/kgbw/day dexamethasone at LD 1-7, 1-14 and 1-21 respectively. The male offspring were sacrificed at 12 weeks of age for the evaluation of hematological indices. Results show that dexamethasone exposure at GD 1-7, 8-14 and 1-21 significantly (PKeywords: Dexamethasone, prenatal, lactational, hematological indices, fetal, corticosterone.


  • Open Access

    Platelet function, anthropometric and metabolic variables in Nigerian Type 2 Diabetic patients

    by S. O. Jeje, S. T. Shittu, A. A. Fasanmade

    This study examined the effects of anthropometric variables and metabolic imbalance on platelet aggregation in diabetic patients. A total of 109 volunteer were used; 58 diabetes mellitus (DM) patients (28 males and 30 females) who were receiving treatment at the University College Hospital Ibadan and 51 non diabetic control recruited from residents of Agbowo and Teachers of some secondary schools within the University of Ibadan. Body mass index (BMI) and body surface area (BSA) were assessed as indices of anthropometry, fasting blood sugar (FBS), plasma cholesterol and triglycerides (TAG) were determined using standard method and platelet aggregation test was done on the whole blood. Platelet aggregation ratio was higher in non diabetic compared to the diabetic subjects (P<0.001). The mean platelet aggregation ratio was also significantly higher in the male diabetic when compared to the female diabetic group (P<0.001). There was a significant linear relationship between platelet aggregation ratio and BMI (P<0.01), age (P0.05), FBS (P< 0.01), plasma cholesterol (P<0.01) and plasma TAG (P<0.05). However, the correlation coefficient between platelet aggregation ratio and BSA is not significant. In the non diabetic control subjects the correlation coefficient is not significant. Findings from this study suggest that, the increased platelet aggregation found in diabetic patients increased significantly with increased BMI but decrease with age. The mean platelet aggregation is also increased significantly with increase metabolic imbalance. Key word: Platelet aggregation, anthropometry, diabetes mellitus, Body mass index (BMI), fasting blood sugar (FBS).

  • Open Access

    Virgin Coconut Oil: Remedial Effects on Renal Dysfunction in Diabetic Rats

    by A. M. Akinnuga, S. O. Jeje, O. Bamidele, E. E. Amaku, F. O. Otogo, V. E. Sunday

    Renal dysfunction is now a prevalent complication of diabetes mellitus. Therefore, this study was carried out to evaluate the remedial effects of virgin coconut oil (VCO) on renal dysfunction in diabetic rats. Fifteen albino Wistar rats were divided into 3 groups that comprise normal control group (Group I) and diabetic control group (Group II) fed with normal rat chows and a diabetic test group (Group III) fed with 10% VCO diet. Group II and Group III were made diabetic by single intraperitoneal injection of 150 mg/kg of freshly prepared alloxan monohydrate. After 72 hours of alloxan injection, fasting blood glucose was tested to confirm diabetes mellitus. After 3 weeks, the animals were anaesthetized and sacrificed to collect blood samples for renal function analysis. The creatinine, urea, and blood urea nitrogen values of Group II were significantly different from those of Group I and Group III at . Also, there was significant difference () in total protein value between Group II (4.42 ± 0.47 mg/dL) and Group I (5.78 ± 0.12 mg/dL) as well as Group III (5.86 ± 0.19 mg/dL), but there was no significant difference between that of Group I and Group III (5.78 ± 0.12 mg/dL and 5.86 ± 0.19 mg/dL, resp.). Thus, VCO is effective in preventing renal damage in diabetic patients.